4Kyu BS,Matsumori A,Sato Y et al.Cardiac persistence of cardioviral RNA detected by polymerase chain reaction in a murine model of dilated cardiomyopathy[J].Circulation,2008,86(2):522-530.
5Brtmetti L, DeSantis ER.Treatment of viral myocarditis ca- used by coxsackievims B[J].Am J Health Syst Pharm, 2008,65(2) : 132.
6Chattopadhyay S, Yamashita M, Zhang Y, et al. The IRF -3/ Bax mediated apoptotic pathway activated by viral cytoplasmic RNA and DNA, inhibits virus replication [J]. J Virol, 2011,85 (8) :3708 -3716.
7Zorc - Pleskovic R, Alibegovib A, Zorc M, et al. Apoptosis of cardiomyocytes in myoearditis [ J ]. Folia Biol ( Praha ) , 2006,52 (1 -2) :6 -9.
8Yue - Chun L, Li - Sha G ,Jiang - Hua R ,etal. Protective effects of carvcdilol in murine model with the coxsackievirus B3 - induced viral myocarditis [J]. J Cardiovasc Pharmacol, 2008, 51 (1) :92 -98.
9Nishio R, Shioi T, Sasayama S, et al. Carvedilol increases the production of interleukin - 12 and interferon - γ and improves the survival of mice infected with the encephalomyocarditis virus [ J ]. J Am Coil Cardiol, 2003,41 (2) :340 - 345.
10Li YC, Ge LS, Yang PL, et al. Carvedilol treatment ameliorates acute coxsackievirus B3 - induced myocarditis associated with ox- idative stress reduction [ J]. Eur J Pharmacol, 2010,640 ( 1 - 3) :112 -116.
